hepatocellular carcinoma
Conditions
Interventions
None listed
Sponsors
Kagoshima Unviersity Graduate School of Medical and Dental Sciences
Kirishima Medical Center Kagoshima Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with hepatocellular carcinoma scheduled to recieve partial hepatectomy.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intra-platelet vascular endothelial growth factor (VEGF) and Angiopoietin-1. Serum and plasma; Hepatocyte growth factor(HGF), Epithelial cell growth factor (EGF), soluble VEGF receptor (sVEGFR-1,2), von Willebrand factor (vWF), platelet derived growth factor-BB (PDGF-BB) | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor necrosis factor alpha (TNFalpha), Interleukine-6 (IL-6) | — |
Countries
Japan
Contacts
Public ContactJun Kadono
Kagoshima Unviersity Graduate School of Medical and Dental Sciences Cardiovascular and Gastroenterological Surgery
Outcome results
None listed